Kolexia
Orbach Daniel
Pédiatrie
Clcc Institut Curie
Paris, France
453 Activités
4 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sarcomes Rhabdomyosarcome Récidive tumorale locale Tumeurs des tissus mous Carcinomes Fibromatose agressive Maladies rares Fibrome Sarcome synovial

Industries

Bayer
2 collaboration(s)
Dernière en 2023
Lilly
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Very rare tumors are not so rare in children
EJC paediatric oncology   01 juin 2024
Olfactory neuroblastoma in children and adolescents: The EXPeRT recommendations for diagnosis and management
EJC paediatric oncology   01 juin 2024
Focus on melanotic neuroectodermal tumor of infancy
EJC paediatric oncology   01 juin 2024
A virtual consultation system for very rare tumors in children and adolescents – an initiative of the European Cooperative Study Group in Rare Tumors in Children (EXPeRT)
EJC paediatric oncology   01 juin 2024
Adenoid cystic carcinoma of the parotid and submandibular glands in children and young adults: A population-based study.
Pediatric blood & cancer   28 février 2024
Reappraisal of prognostic factors used in the European Pediatric Soft Tissue Sarcoma Study Group RMS 2005 study for localized rhabdomyosarcoma to optimize risk stratification and generate a prognostic nomogram.
Cancer   24 février 2024
Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord-stromal tumors. Results of the TGM13 National Registry.
Pediatric blood & cancer   23 janvier 2024
Imaging characterization of paediatric tumours with the neurotrophic tyrosine receptor kinase fusion transcript.
The British journal of radiology   16 janvier 2024
A 2023 inventory in oncology news.
Bulletin du cancer   05 janvier 2024
Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers.
Cell reports. Medicine   22 décembre 2023